AIMS: Monogenic diabetes is frequently misdiagnosed as Type 1 diabetes. We aimed to screen for undiagnosed monogenic diabetes in a cohort of children who had a clinical diagnosis of Type 1 diabetes but were pancreatic autoantibody-negative. METHODS: We studied 252 patients diagnosed clinically with Type 1 diabetes between 6 months and 17 years of age. Pancreatic autoantibodies [islet cell autoantibodies (ICA), glutamic acid decarboxylase antibodies (GADA) and/or insulinoma-associated antigen-2 antibodies (IA2A)] were absent in 25 cases (9.9%). The most frequent genes involved in monogenic diabetes [KCNJ11 and INS for neonatal diabetes and HNF1A and HNF4A for maturity-onset diabetes of the young (MODY)] were directly sequenced. RESULTS: Two of the 25 (8%) antibody-negative patients had de novo heterozygous mutations in INS; c.94G>A (G32S) and c.265C>T (R89C). The two patients presented with non-ketotic hyperglycaemia at 8 and 11 months of age. In contrast, the four antibody-positive patients who presented at a similar age (6-12 months) had a more severe metabolic derangement, manifested as ketosis in all four cases, with ketoacidosis in two. At ages 15 and 5 years, both INS mutation patients were prescribed a replacement dose of insulin with good glycaemic control [glycated haemoglobin (HbA(1c)) 7.0 and 7.2%]. No mutations were found in KCNJ11, HNF1A or HNF4A. CONCLUSIONS: The identification of patients with monogenic diabetes from children with clinically defined Type 1 diabetes may be helped by clinical criteria including the absence of pancreatic autoantibodies.
AIMS: Monogenic diabetes is frequently misdiagnosed as Type 1 diabetes. We aimed to screen for undiagnosed monogenic diabetes in a cohort of children who had a clinical diagnosis of Type 1 diabetes but were pancreatic autoantibody-negative. METHODS: We studied 252 patients diagnosed clinically with Type 1 diabetes between 6 months and 17 years of age. Pancreatic autoantibodies [islet cell autoantibodies (ICA), glutamic acid decarboxylase antibodies (GADA) and/or insulinoma-associated antigen-2 antibodies (IA2A)] were absent in 25 cases (9.9%). The most frequent genes involved in monogenic diabetes [KCNJ11 and INS for neonatal diabetes and HNF1A and HNF4A for maturity-onset diabetes of the young (MODY)] were directly sequenced. RESULTS: Two of the 25 (8%) antibody-negative patients had de novo heterozygous mutations in INS; c.94G>A (G32S) and c.265C>T (R89C). The two patients presented with non-ketotic hyperglycaemia at 8 and 11 months of age. In contrast, the four antibody-positive patients who presented at a similar age (6-12 months) had a more severe metabolic derangement, manifested as ketosis in all four cases, with ketoacidosis in two. At ages 15 and 5 years, both INS mutation patients were prescribed a replacement dose of insulin with good glycaemic control [glycated haemoglobin (HbA(1c)) 7.0 and 7.2%]. No mutations were found in KCNJ11, HNF1A or HNF4A. CONCLUSIONS: The identification of patients with monogenic diabetes from children with clinically defined Type 1 diabetes may be helped by clinical criteria including the absence of pancreatic autoantibodies.
Authors: Ming Liu; Israel Hodish; Leena Haataja; Roberto Lara-Lemus; Gautam Rajpal; Jordan Wright; Peter Arvan Journal: Trends Endocrinol Metab Date: 2010-08-18 Impact factor: 12.015
Authors: Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson Journal: Trends Endocrinol Metab Date: 2010-04-29 Impact factor: 12.015
Authors: Sven Pörksen; Lene Bjerke Laborie; Lotte Nielsen; Marie Louise Max Andersen; Tone Sandal; Heidi de Wet; Erik Schwarcz; Jan Aman; Peter Swift; Mirjana Kocova; Eugen J Schönle; Carine de Beaufort; Philip Hougaard; Frances Ashcroft; Anders Molven; Mikael Knip; Henrik B Mortensen; Lars Hansen; Pål R Njølstad Journal: BMC Endocr Disord Date: 2010-09-23 Impact factor: 2.763
Authors: Julie Støy; Donald F Steiner; Soo-Young Park; Honggang Ye; Louis H Philipson; Graeme I Bell Journal: Rev Endocr Metab Disord Date: 2010-09 Impact factor: 6.514
Authors: Shu-Qin Lei; Jie-Ying Wang; Rong-Min Li; Jie Chang; Zhen Li; Li Ren; Yan-Mei Sang Journal: Am J Transl Res Date: 2020-10-15 Impact factor: 4.060
Authors: Rachelle G Gandica; Wendy K Chung; Liyong Deng; Robin Goland; Mary Pat Gallagher Journal: Pediatr Diabetes Date: 2014-08-01 Impact factor: 4.866
Authors: Halley Wasserman; Robert B Hufnagel; Virginia Miraldi Utz; Kejian Zhang; C Alexander Valencia; Nancy D Leslie; Nancy A Crimmins Journal: Pediatr Diabetes Date: 2015-11-04 Impact factor: 4.866